Design of pyrozolo-pyrimidines as 11beta-HSD1 inhibitors through optimisation of molecular electrostatic potential.
Robb, G.R., Boyd, S., Davies, C.D., Dossiter, A.G., Goldberg, F.W., Kemmitt, P.D., Scott, J.S., Swales, J.G.(2016) Medchemcomm 6: 926-934
- DOI: https://doi.org/10.1039/C5MD00043B